Lesion SUVmax
| Lesion SUVmax on 64Cu-DOTATATE PET | ||||
| Organ or tissue | n* | 1 h after injection | 3 h after injection | P† |
| Lung | 5 | 17.9 [3.0–32.9] | 18.7 [5.3–32.1] | 1.00 |
| Liver | 22 | 45.7 [37.2–54.3] | 54.1 [44.3–64.0] | <0.01 |
| Intestines | 12 | 64.4 [43.9–84.8] | 77.8 [52.3–103.3] | 0.19 |
| Pancreas | 8 | 79.0 [38.3–119.6] | 85.9 [35.9–135.8] | 1.00 |
| Bone | 12 | 44.2 [25.7–62.7] | 50.1 [29.7–70.4] | 0.46 |
| Intraabdominal carcinomatosis | 4 | 23.0 [7.7–38.3] | 24.9 [9.0–40.7] | 1.00 |
| Lymph nodes | 18‡ | 40.9 [26.9–54.9] | 43.5 [29.1–58.0] | 0.76 |
↵* Number of patients with lesions.
↵† Paired t testing with Bonferroni adjustment for multiple comparisons (n = 7) and capped at 1.00.
↵‡ n = 19 on 64Cu-DOTATATE PET at 3 h after injection (one additional lymph node lesion detected in 1 patient).
Data are mean values followed by 95% confidence interval in brackets.